Antibody data
- Antibody Data
- Antigen structure
- References [12]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 14881-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#14881-1-AP, RRID:AB_2218248
- Product name
- YWHAZ antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated YWHAZ antibody (Cat. #14881-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: WB, ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references YY1-modulated long non-coding RNA SNHG12 promotes gastric cancer metastasis by activating the miR-218-5p/YWHAZ axis.
High Dietary Fat Consumption Impairs Axonal Mitochondrial Function In Vivo.
YWHAZ interacts with DAAM1 to promote cell migration in breast cancer.
Integrated lipidomic and transcriptomic analyses identify altered nerve triglycerides in mouse models of prediabetes and type 2 diabetes.
1,3-Dicaffeoylquinic acid targeting 14-3-3 tau suppresses human breast cancer cell proliferation and metastasis through IL6/JAK2/PI3K pathway.
YWHAZ Binds to TRIM21 but Is Not Involved in TRIM21-stimulated Osteosarcoma Cell Proliferation.
TRIP13 promotes tumor growth and is associated with poor prognosis in colorectal cancer.
The ASH1-miR-375-YWHAZ Signaling Axis Regulates Tumor Properties in Hepatocellular Carcinoma.
CUE domain-containing protein 2 promotes the Warburg effect and tumorigenesis.
c-Myc suppresses miR-451⊣YWTAZ/AKT axis via recruiting HDAC3 in acute myeloid leukemia.
miR-155 downregulates ErbB2 and suppresses ErbB2-induced malignant transformation of breast epithelial cells.
Lysine-specific demethylase 1 promotes the stemness and chemoresistance of Lgr5(+) liver cancer initiating cells by suppressing negative regulators of β-catenin signaling.
Zhang T, Beeharry MK, Wang Z, Zhu Z, Li J, Li C
International journal of biological sciences 2021;17(7):1629-1643
International journal of biological sciences 2021;17(7):1629-1643
High Dietary Fat Consumption Impairs Axonal Mitochondrial Function In Vivo.
Sajic M, Rumora AE, Kanhai AA, Dentoni G, Varatharajah S, Casey C, Brown RDR, Peters F, Hinder LM, Savelieff MG, Feldman EL, Smith KJ
The Journal of neuroscience : the official journal of the Society for Neuroscience 2021 May 12;41(19):4321-4334
The Journal of neuroscience : the official journal of the Society for Neuroscience 2021 May 12;41(19):4321-4334
YWHAZ interacts with DAAM1 to promote cell migration in breast cancer.
Mei J, Liu Y, Yu X, Hao L, Ma T, Zhan Q, Zhang Y, Zhu Y
Cell death discovery 2021 Aug 27;7(1):221
Cell death discovery 2021 Aug 27;7(1):221
Integrated lipidomic and transcriptomic analyses identify altered nerve triglycerides in mouse models of prediabetes and type 2 diabetes.
O'Brien PD, Guo K, Eid SA, Rumora AE, Hinder LM, Hayes JM, Mendelson FE, Hur J, Feldman EL
Disease models & mechanisms 2020 Jan 24;13(2)
Disease models & mechanisms 2020 Jan 24;13(2)
1,3-Dicaffeoylquinic acid targeting 14-3-3 tau suppresses human breast cancer cell proliferation and metastasis through IL6/JAK2/PI3K pathway.
Zhou Y, Fu X, Guan Y, Gong M, He K, Huang B
Biochemical pharmacology 2020 Feb;172:113752
Biochemical pharmacology 2020 Feb;172:113752
YWHAZ Binds to TRIM21 but Is Not Involved in TRIM21-stimulated Osteosarcoma Cell Proliferation.
Zeng QZ, Liu WT, Lu JL, Liu XH, Zhang YF, Liu LX, Gao XJ
Biomedical and environmental sciences : BES 2018 Mar;31(3):186-196
Biomedical and environmental sciences : BES 2018 Mar;31(3):186-196
TRIP13 promotes tumor growth and is associated with poor prognosis in colorectal cancer.
Sheng N, Yan L, Wu K, You W, Gong J, Hu L, Tan G, Chen H, Wang Z
Cell death & disease 2018 Mar 14;9(3):402
Cell death & disease 2018 Mar 14;9(3):402
The ASH1-miR-375-YWHAZ Signaling Axis Regulates Tumor Properties in Hepatocellular Carcinoma.
Zhao JF, Zhao Q, Hu H, Liao JZ, Lin JS, Xia C, Chang Y, Liu J, Guo AY, He XX
Molecular therapy. Nucleic acids 2018 Jun 1;11:538-553
Molecular therapy. Nucleic acids 2018 Jun 1;11:538-553
CUE domain-containing protein 2 promotes the Warburg effect and tumorigenesis.
Zhong X, Tian S, Zhang X, Diao X, Dong F, Yang J, Li Z, Sun L, Wang L, He X, Wu G, Hu X, Wang L, Song L, Zhang H, Pan X, Li A, Gao P
EMBO reports 2017 May;18(5):809-825
EMBO reports 2017 May;18(5):809-825
c-Myc suppresses miR-451⊣YWTAZ/AKT axis via recruiting HDAC3 in acute myeloid leukemia.
Su R, Gong JN, Chen MT, Song L, Shen C, Zhang XH, Yin XL, Ning HM, Liu B, Wang F, Ma YN, Zhao HL, Yu J, Zhang JW
Oncotarget 2016 Nov 22;7(47):77430-77443
Oncotarget 2016 Nov 22;7(47):77430-77443
miR-155 downregulates ErbB2 and suppresses ErbB2-induced malignant transformation of breast epithelial cells.
He XH, Zhu W, Yuan P, Jiang S, Li D, Zhang HW, Liu MF
Oncogene 2016 Nov 17;35(46):6015-6025
Oncogene 2016 Nov 17;35(46):6015-6025
Lysine-specific demethylase 1 promotes the stemness and chemoresistance of Lgr5(+) liver cancer initiating cells by suppressing negative regulators of β-catenin signaling.
Lei ZJ, Wang J, Xiao HL, Guo Y, Wang T, Li Q, Liu L, Luo X, Fan LL, Lin L, Mao CY, Wang SN, Wei YL, Lan CH, Jiang J, Yang XJ, Liu PD, Chen DF, Wang B
Oncogene 2015 Jun 11;34(24):3188-98
Oncogene 2015 Jun 11;34(24):3188-98
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The YWHAZ antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human YWHAZ. This antibody recognizes human,mouse,rat antigen. The YWHAZ antibody has been validated for the following applications: ELISA, WB analysis.